CD4 and neoplasm: We discovered that the antitumor immune system was promoted in MOC1CX3CL1 tumors, as demonstrated by recruitment of a higher number of cytotoxic T cells, alongside simulation of the pro-tumor immune system in MOC2CX3CL1 tumors when CD4+ T cells and Treg cells are recruited.